{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T10:04:33Z","timestamp":1785492273678,"version":"3.56.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":69,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Jiangsu Provincial Medical Key Discipline","award":["ZDXK202207"],"award-info":[{"award-number":["ZDXK202207"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-026-03159-3","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T16:50:17Z","timestamp":1775753417000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hepatic metabolic burden and all-cause mortality across glucose metabolism statuses in a cardiovascular-kidney-metabolic syndrome population: insights from the National Health and Nutrition Examination Survey (NHANES)"],"prefix":"10.1186","volume":"25","author":[{"given":"Tao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiming","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"issue":"20","key":"3159_CR1","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS, Coresh J, Mathew RO, Baker-Smith CM, Carnethon MR, et al. Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association. Circulation. 2023;148 (20):1606\u201335.","journal-title":"Circulation"},{"issue":"21","key":"3159_CR2","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1001\/jama.2024.6892","volume":"331","author":"R Aggarwal","year":"2024","unstructured":"Aggarwal R, Ostrominski JW, Vaduganathan M. Prevalence of cardiovascular-kidney-metabolic syndrome stages in US adults, 2011\u20132020. JAMA. 2024;331 (21):1858\u201360.","journal-title":"JAMA"},{"issue":"18","key":"3159_CR3","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1001\/jama.2021.5469","volume":"325","author":"FB Ahmad","year":"2021","unstructured":"Ahmad FB, Anderson RN. The leading causes of death in the US for 2020. JAMA. 2021;325 (18):1829\u201330.","journal-title":"JAMA"},{"key":"3159_CR4","doi-asserted-by":"publisher","first-page":"101138","DOI":"10.1016\/j.molmet.2020.101138","volume":"44","author":"SO Jensen-Cody","year":"2021","unstructured":"Jensen-Cody SO, Potthoff MJ. Hepatokines and metabolism: deciphering communication from the liver. Mol Metab. 2021;44:101138.","journal-title":"Mol Metab"},{"issue":"6","key":"3159_CR5","doi-asserted-by":"publisher","first-page":"4995","DOI":"10.3390\/nu7064995","volume":"7","author":"E Fabbrini","year":"2015","unstructured":"Fabbrini E, Magkos F. Hepatic steatosis as a marker of metabolic dysfunction. Nutrients. 2015;7 (6):4995\u20135019.","journal-title":"Nutrients"},{"issue":"3","key":"3159_CR6","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","volume":"81","author":"EASL-EASD-EASO Clinical","year":"2024","unstructured":"EASL-EASD-EASO Clinical. Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol. 2024;81 (3):492\u2013542.","journal-title":"J Hepatol"},{"issue":"1","key":"3159_CR7","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1186\/s12933-024-02434-5","volume":"23","author":"H Zheng","year":"2024","unstructured":"Zheng H, Sechi LA, Navarese EP, Casu G, Vidili G. Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review. Cardiovasc Diabetol. 2024;23 (1):346.","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"3159_CR8","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1161\/ATV.0000000000000153","volume":"42","author":"PB Duell","year":"2022","unstructured":"Duell PB, Welty FK, Miller M, Chait A, Hammond G, Ahmad Z, Cohen DE, Horton JD, Pressman GS, Toth PP. Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association. Arterioscler Thromb Vasc Biol. 2022;42 (6):e168\u201385.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3159_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33.","journal-title":"BMC Gastroenterol"},{"issue":"10","key":"3159_CR10","doi-asserted-by":"publisher","first-page":"6018","DOI":"10.1111\/dom.16595","volume":"27","author":"A Goyal","year":"2025","unstructured":"Goyal A, Kubihal S, Gupta Y, Shalimar, Kandasamy D, Kalaivani M, Tandon N. Hepatic steatosis index for prediction of metabolic dysfunction-associated steatotic liver disease (MASLD) among young Indian women with gestational diabetes and normoglycaemia during index pregnancy. Diabetes Obes Metab. 2025;27 (10):6018\u201322.","journal-title":"Diabetes Obes Metab"},{"key":"3159_CR11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2147\/DMSO.S189544","volume":"12","author":"AR Khang","year":"2019","unstructured":"Khang AR, Lee HW, Yi D, Kang YH, Son SM. The fatty liver index, a simple and useful predictor of metabolic syndrome: analysis of the Korea National Health and Nutrition Examination Survey 2010\u20132011. Diabetes Metab Syndr Obes. 2019;12:181\u201390.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"3159_CR12","first-page":"1","volume":"1","author":"A Lonardo","year":"2021","unstructured":"Lonardo A, Ballestri S, Bedogni G, Bellentani S, Tiribelli C. The Fatty liver Index (FLI) 15 years later: A reappraisal. Metabolism Target Organ Damage. 2021;1:1\u201320.","journal-title":"Metabolism Target Organ Damage"},{"issue":"1","key":"3159_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s11739-024-03758-6","volume":"20","author":"SH Park","year":"2025","unstructured":"Park SH, Park J, Kim H, Lee J, Kwon SY, Lee YB, Kim G, Jin SM, Hur KY, Kim JH. The association of fatty liver index and metabolic syndrome with cardiovascular outcomes, liver-related mortality, and all-cause mortality: a nationwide cohort study. Intern Emerg Med. 2025;20 (1):105\u201317.","journal-title":"Intern Emerg Med"},{"issue":"6","key":"3159_CR14","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.4093\/dmj.2025.0992","volume":"49","author":"J Lee","year":"2025","unstructured":"Lee J, Han K. Association between fatty liver index and incident diabetes according to alcohol consumption status in young adults. Diabetes Metab J. 2025;49 (6):1342\u20135.","journal-title":"Diabetes Metab J"},{"key":"3159_CR15","doi-asserted-by":"crossref","unstructured":"Kim BS, Kim HJ, Kim H, Lee J, Ahn SB, Shin JH, Lim YH. Hepatic Steatosis in Cardiovascular-Kidney-Metabolic Syndrome: Fatty Liver Index as a Predictor of Cardiovascular Outcomes. Eur J Prev Cardiol 2025.","DOI":"10.1093\/eurjpc\/zwaf396"},{"issue":"9833","key":"3159_CR16","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1016\/S0140-6736(12)60283-9","volume":"379","author":"AG Tab\u00e1k","year":"2012","unstructured":"Tab\u00e1k AG, Herder C, Rathmann W, Brunner EJ, Kivim\u00e4ki M. Prediabetes: a high-risk state for diabetes development. Lancet. 2012;379 (9833):2279\u201390.","journal-title":"Lancet"},{"issue":"5","key":"3159_CR17","doi-asserted-by":"publisher","first-page":"E1009","DOI":"10.1152\/ajpendo.90558.2008","volume":"295","author":"JE Galgani","year":"2008","unstructured":"Galgani JE, Moro C, Ravussin E. Metabolic flexibility and insulin resistance. Am J Physiol Endocrinol Metab. 2008;295 (5):E1009\u20131017.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"5","key":"3159_CR18","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S2213-8587(18)30027-5","volume":"6","author":"MK Ali","year":"2018","unstructured":"Ali MK, Bullard KM, Saydah S, Imperatore G, Gregg EW. Cardiovascular and renal burdens of prediabetes in the USA: analysis of data from serial cross-sectional surveys, 1988\u20132014. Lancet Diabetes Endocrinol. 2018;6 (5):392\u2013403.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"3159_CR19","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/nrgastro.2016.147","volume":"14","author":"H Tilg","year":"2017","unstructured":"Tilg H, Moschen AR, Roden M. NAFLD and diabetes mellitus. Nat Rev Gastroenterol Hepatol. 2017;14 (1):32\u201342.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3159_CR20","doi-asserted-by":"crossref","unstructured":"Muzica CM, Sfarti C, Trifan A, Zenovia S, Cuciureanu T, Nastasa R, Huiban L, Cojocariu C, Singeap AM, Girleanu I et al. Nonalcoholic fatty liver disease and type 2 diabetes mellitus: a bidirectional relationship. Can J Gastroenterol Hepatol 2020, 2020:6638306.","DOI":"10.1155\/2020\/6638306"},{"issue":"9","key":"3159_CR21","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang Y, Castro AF III, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150 (9):604\u201312.","journal-title":"Ann Intern Med"},{"issue":"Suppl 1","key":"3159_CR22","first-page":"S11","volume":"33","author":"Standards of medical care in diabetes","year":"2010","unstructured":"Standards of medical care in diabetes\u20132010. Diabetes Care. 2010;33 (Suppl 1):S11\u201361.","journal-title":"Diabetes Care"},{"issue":"10","key":"3159_CR23","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1210\/clinem\/dgab415","volume":"106","author":"KA MacGregor","year":"2021","unstructured":"MacGregor KA, Gallagher IJ, Moran CN. Relationship between insulin sensitivity and menstrual cycle is modified by BMI, fitness, and physical activity in NHANES. J Clin Endocrinol Metab. 2021;106 (10):2979\u201390.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"3159_CR24","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, Torriani MSS, Dieterich FJ, Thomas DT. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology. 2006;43 (6):1317\u201325.","journal-title":"Hepatology"},{"key":"3159_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v045.i03","volume":"45","author":"S Van Buuren","year":"2011","unstructured":"Van Buuren S, Groothuis-Oudshoorn K. mice: Multivariate imputation by chained equations in R. J Stat Softw. 2011;45:1\u201367.","journal-title":"J Stat Softw"},{"issue":"9467","key":"3159_CR26","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/S0140-6736(05)61032-X","volume":"365","author":"M Stumvoll","year":"2005","unstructured":"Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet. 2005;365 (9467):1333\u201346.","journal-title":"Lancet"},{"issue":"1","key":"3159_CR27","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1172\/JCI77812","volume":"126","author":"VT Samuel","year":"2016","unstructured":"Samuel VT, Shulman GI. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. J Clin Invest. 2016;126 (1):12\u201322.","journal-title":"J Clin Invest"},{"issue":"1","key":"3159_CR28","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12933-025-02824-3","volume":"24","author":"E Han","year":"2025","unstructured":"Han E, Han KD, Lee YH, Kim KS, Hong S, Park JH, Park CY. Association of temporal MASLD with type 2 diabetes, cardiovascular disease and mortality. Cardiovasc Diabetol. 2025;24 (1):289.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3159_CR29","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s12933-022-01725-z","volume":"21","author":"J Park","year":"2022","unstructured":"Park J, Kim G, Kim H, Lee J, Jin SM, Kim JH. The associations between changes in hepatic steatosis and heart failure and mortality: a nationwide cohort study. Cardiovasc Diabetol. 2022;21 (1):287.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3159_CR30","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s12933-022-01691-6","volume":"21","author":"GE Chung","year":"2022","unstructured":"Chung GE, Jeong SM, Cho EJ, Yoon JW, Yoo JJ, Cho Y, Lee KN, Shin DW, Kim YJ, Yoon JH, et al. The association of fatty liver index and BARD score with all-cause and cause-specific mortality in patients with type 2 diabetes mellitus: a nationwide population-based study. Cardiovasc Diabetol. 2022;21 (1):273.","journal-title":"Cardiovasc Diabetol"},{"issue":"7","key":"3159_CR31","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.cmet.2021.06.006","volume":"33","author":"CD Green","year":"2021","unstructured":"Green CD, Maceyka M, Cowart LA, Spiegel S. Sphingolipids in metabolic disease: the good, the bad, and the unknown. Cell Metab. 2021;33 (7):1293\u2013306.","journal-title":"Cell Metab"},{"issue":"45","key":"3159_CR32","doi-asserted-by":"publisher","first-page":"17402","DOI":"10.1073\/pnas.0802781105","volume":"105","author":"GG Guenther","year":"2008","unstructured":"Guenther GG, Peralta ER, Rosales KR, Wong SY, Siskind LJ, Edinger AL. Ceramide starves cells to death by downregulating nutrient transporter proteins. Proc Natl Acad Sci U S A. 2008;105 (45):17402\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"3159_CR33","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/S2468-1253(21)00020-0","volume":"6","author":"G Targher","year":"2021","unstructured":"Targher G, Tilg H, Byrne CD. Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach. Lancet Gastroenterol Hepatol. 2021;6 (7):578\u201388.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"3159_CR34","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12933-024-02287-y","volume":"23","author":"Y Min","year":"2024","unstructured":"Min Y, Wei X, Wei Z, Song G, Zhao X, Lei Y. Prognostic effect of triglyceride glucose-related parameters on all-cause and cardiovascular mortality in the United States adults with metabolic dysfunction-associated steatotic liver disease. Cardiovasc Diabetol. 2024;23 (1):188.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3159_CR35","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12933-025-02784-8","volume":"24","author":"X Wang","year":"2025","unstructured":"Wang X, Wen P, Liao Y, Wu T, Zeng L, Huang Y, Song X, Xiong Z, Deng L, Li D, et al. Association of atherogenic index of plasma and its modified indices with stroke risk in individuals with cardiovascular-kidney-metabolic syndrome stages 0\u20133: a longitudinal analysis based on CHARLS. Cardiovasc Diabetol. 2025;24 (1):254.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3159_CR36","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12933-025-02742-4","volume":"24","author":"Q Zheng","year":"2025","unstructured":"Zheng Q, Cao Z, Teng J, Lu Q, Huang P, Zhou J. Association between atherogenic index of plasma with all-cause and cardiovascular mortality in individuals with Cardiovascular-Kidney-Metabolic syndrome. Cardiovasc Diabetol. 2025;24 (1):183.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3159_CR37","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12933-025-02642-7","volume":"24","author":"P Zhang","year":"2025","unstructured":"Zhang P, Mo D, Zeng W, Dai H. Association between triglyceride-glucose related indices and all-cause and cardiovascular mortality among the population with cardiovascular-kidney-metabolic syndrome stage 0\u20133: a cohort study. Cardiovasc Diabetol. 2025;24 (1):92.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3159_CR38","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13098-025-01649-0","volume":"17","author":"C Zhang","year":"2025","unstructured":"Zhang C, Hao C, Liang W, Hu K, Guo T, Chen Y, Ning M, Liu Y. Abdominal obesity and frailty progression in population across different Cardiovascular-Kidney-Metabolic syndrome stages: a nationwide longitudinal study. Diabetol Metab Syndr. 2025;17 (1):75.","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"3159_CR39","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/s12933-025-02826-1","volume":"24","author":"J Liu","year":"2025","unstructured":"Liu J, Kang J, Liang P, Song Z, Li G, Jin X, Wu H. The association between triglyceride-glucose index and all-cause\/cardiovascular mortality in patients with different glucose metabolism statuses. Cardiovasc Diabetol. 2025;24 (1):367.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3159_CR40","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12933-024-02163-9","volume":"23","author":"X Wu","year":"2024","unstructured":"Wu X, Qiu W, Yang H, Chen YJ, Liu J, Zhao G. Associations of the triglyceride-glucose index and atherogenic index of plasma with the severity of new-onset coronary artery disease in different glucose metabolic states. Cardiovasc Diabetol. 2024;23 (1):76.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3159_CR41","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12933-024-02355-3","volume":"23","author":"S Zhao","year":"2024","unstructured":"Zhao S, Wang Z, Qing P, Li M, Liu Q, Pang X, Wang K, Gao X, Zhao J, Wu Y. Comprehensive analysis of the association between triglyceride-glucose index and coronary artery disease severity across different glucose metabolism states: a large-scale cross-sectional study from an Asian cohort. Cardiovasc Diabetol. 2024;23 (1):251.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3159_CR42","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12933-025-02793-7","volume":"24","author":"YS Lyu","year":"2025","unstructured":"Lyu YS, Park M, Kim HK, Park S, Park JY, Hong AR, Yoon JH, Jeong S, Yoon Y, Kim JH, et al. Combined impact of prediabetes and fatty liver index on cardiometabolic outcomes and mortality in middle aged adults: a nationwide cohort study. Cardiovasc Diabetol. 2025;24 (1):279.","journal-title":"Cardiovasc Diabetol"},{"key":"3159_CR43","doi-asserted-by":"publisher","first-page":"120557","DOI":"10.1016\/j.atherosclerosis.2025.120557","volume":"411","author":"S Wissel","year":"2025","unstructured":"Wissel S, Scharnagl H, Kleber ME, Delgado G, Moissl A, Kr\u00e4mer B, M\u00e4rz W. Fatty liver-index, systemic inflammation and cardiovascular mortality. Results from the LURIC study. Atherosclerosis. 2025;411:120557.","journal-title":"Atherosclerosis"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03159-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03159-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03159-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:02:02Z","timestamp":1781658122000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03159-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3159"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03159-3","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"29 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants in NHANES provided written informed consent prior to participation, and all survey procedures were reviewed and approved by the institutional review board of the National Center for Health Statistics.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"181"}}